
July 7, 2023
FDA Comments Submission: Patient Focused Drug Development - Draft Guidance #4

April 27, 2023
FDA’s patient-focused drug development guidance recommends Goal Attainment Scaling (GAS) as a personalized endpoint

September 1, 2022
The Inchstone Project submits comments to the FDA draft guidance on “Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-for-Purpose Clinical Outcome Assessments.”

January 11, 2022
Ardea Outcomes partners with Mitacs and University of Alberta on a Goal Attainment Scaling research project

January 1, 2022
Jacinda Ardern awards Dr. Ken Rockwood, Ardea Outcomes' Co-Founder, the 2021 Ryman Prize

December 1, 2021